A ppendix 2 Additional FDA Analysis for Protocol 20063: The reader study was evaluated to compare the sensitivity and specificity of MelaFind to the average sensitivity and average specificity of biopsy referral of all t - Positive predictive value - Document - PDFSEARCH.IO

First Page	Meta Content
	A ppendix 2 Additional FDA Analysis for Protocol 20063: The reader study was evaluated to compare the sensitivity and specificity of MelaFind to the average sensitivity and average specificity of biopsy/referral of all t Add to Reading List Open Document File Size: 102,57 KB Share Result on Facebook MedicalCondition melanoma / / Organization FDA / / Position General / / SocialTag Statistical theory Categorical data Evidence-based medicine Negative predictive value Likelihood ratios in diagnostic testing Sensitivity and specificity Melanoma Accuracy and precision Positive predictive value Statistics

A ppendix 2 Additional FDA Analysis for Protocol 20063: The reader study was evaluated to compare the sensitivity and specificity of MelaFind to the average sensitivity and average specificity of biopsy/referral of all tAdd to Reading List